NasdaqCM:NAGEPersonal Products
Niagen Bioscience (NAGE) Q1 Net Income Beat Reinforces Bullish Margin Narratives
Niagen Bioscience (NAGE) just posted its Q1 2026 numbers, with revenue of US$31.5 million and basic EPS of US$0.08, setting the tone for how the year is starting to shape up on the top and bottom line. The company has seen quarterly revenue move from US$29.1 million in Q4 2024 to a range of roughly US$30.5 million to US$34.0 million through 2025, while basic EPS has run between US$0.05 and US$0.09 over the same stretch, giving you a clearer feel for how Q1 2026 fits into the recent trend...